Journal of neurosurgery
-
Journal of neurosurgery · Feb 2012
Meta AnalysisAtypia predicting prognosis for intracranial extraventricular neurocytomas.
The literature, at present, provides limited information about extraventricular neurocytomas (EVNs) and is almost exclusively composed of case reports or small case series. Treatment for EVNs has largely been guided by results from central neurocytoma outcome studies. The authors present an analysis of all reported intracranial EVN cases to establish if tumor histopathological features can substratify EVN into groups with differing prognosis and help guide treatment decisions. ⋯ There are at least 2 distinct histological subtypes of EVN, with different prognostic significances. Atypia or MIB-1 labeling index greater than 3% is a significant predictor of poor prognosis for EVNs. Complete resection or more aggressive attempts at providing adjuvant therapy following STR appear to improve the prognosis for patients with EVNs. Although the authors' results are informative, there are limitations to their analysis. Given the relatively modest total number of cases reported, as well as the nature of the disaggregated analysis, the authors were not able to use formal meta-analytical methods to limit the impact of between center heterogeneity. Additionally, they were not able to control for individual differences in data analysis and presentation across the different studies included in their analysis.
-
Journal of neurosurgery · Feb 2012
Clinical TrialA clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma.
The presence of angiogenesis is a hallmark of glioblastoma (GBM). Vascular endothelial growth factor (VEGF), which drives angiogenesis, provides an additional target for conventional therapy. The authors conducted a prospective clinical trial to test the effectiveness of bevacizumab, an inhibitor of VEGF, in newly diagnosed GBM. ⋯ The addition of bevacizumab to conventional therapy in newly diagnosed GBM appears to improve both PFS and OS in patients with newly diagnosed GBM, with acceptable morbidity. A shift toward diffuse relapse was noted in a significant number of patients. Ongoing Phase III clinical trials will show the true benefit of this antiangiogenic approach.
-
Journal of neurosurgery · Feb 2012
Multicenter Study Clinical TrialA multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression.
Deep brain stimulation (DBS) has been recently investigated as a treatment for major depression. One of the proposed targets for this application is the subcallosal cingulate gyrus (SCG). To date, promising results after SCG DBS have been reported by a single center. In the present study the authors investigated whether these findings may be replicated at different institutions. They conducted a 3-center prospective open-label trial of SCG DBS for 12 months in patients with treatment-resistant depression. ⋯ Overall, findings from this study corroborate the results of previous reports showing that outcome of SCG DBS may be replicated across centers.
-
Journal of neurosurgery · Feb 2012
Case ReportsAn episode of severely suppressed electrocerebral activity recorded by electroencephalography during endoscopic resection of a colloid cyst.
Intraoperative neuromonitoring utilizing electroencephalography (EEG) is rarely performed during neuroendoscopy. The authors present a case in which this monitoring modality was used for a patient with a colloid cyst in preparation for an open craniotomy should an endoscopic approach fail. ⋯ Although they describe a transient phenomenon that resulted in no residual cognitive or neurological deficits, the importance of cautious introduction of ventricular irrigation, the need to carefully monitor intracranial pressure during neuroendoscopic procedures, and the need to pay close attention to irrigation temperature and composition should not be underestimated. Additional studies regarding the utility of EEG in alerting neurosurgeons to adverse electrical cerebral activity during neuroendoscopy are warranted.